Evidence
What the research shows
Ipamorelin is a potent growth hormone secretagogue with a unique mechanism of action that selectively targets the ghrelin receptor. In preclinical studies, it has demonstrated significant potential for stimulating growth hormone release while minimizing side effects associated with other secretagogues. Research indicates that its targeted receptor profile can enhance the understanding of metabolic and endocrine responses, making it a valuable tool for scientists exploring these pathways.